|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1997-1-2
|
|
pubmed:abstractText |
In a prospective, randomized open trial, significantly higher patency rates were observed 60 minutes after beginning fibrinolytic therapy for acute myocardial infarction after administration of 3 million U streptokinase as compared to 1.5 million U (Thrombolysis in Myocardial Infarction [TIMI] grade 2 and 3 in 52% vs 26%; p = 0.04). Adverse events were observed with similar frequency in both groups.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9149
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1167-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8914885-Adult,
pubmed-meshheading:8914885-Aged,
pubmed-meshheading:8914885-Blood Pressure,
pubmed-meshheading:8914885-Coronary Angiography,
pubmed-meshheading:8914885-Coronary Vessels,
pubmed-meshheading:8914885-Dose-Response Relationship, Drug,
pubmed-meshheading:8914885-Drug Administration Schedule,
pubmed-meshheading:8914885-Female,
pubmed-meshheading:8914885-Humans,
pubmed-meshheading:8914885-Male,
pubmed-meshheading:8914885-Middle Aged,
pubmed-meshheading:8914885-Monitoring, Physiologic,
pubmed-meshheading:8914885-Myocardial Infarction,
pubmed-meshheading:8914885-Prospective Studies,
pubmed-meshheading:8914885-Streptokinase,
pubmed-meshheading:8914885-Vascular Patency
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
High-dose streptokinase therapy with three million units in one hour significantly improves early coronary patency rates in acute myocardial infarction.
|
|
pubmed:affiliation |
Medizinische Klinik der Technischen Universität München, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
